The
report titled “APAC
Healthcare AI Market Outlook to 2025 – By Applications (Machine/Robot Assisted
Medical Procedures, Clinical Trial & Drug Discovery/Development,
Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing
Assistant, Fraud Detection, Dosage Error Reduction), by Countries, by End Users
& by Technologies and Current Investment Scenario” covers market size by revenue generated by
Artificial Intelligence providers in Healthcare Market in Asia Pacific region
along with market segmentation by Technology (Deep Learning Method, Querying
Method, Natural Language Processing and Context Aware Processing), by
Application (Machine/Robot Assisted Medical Procedures, Clinical Trial &
Drug Discovery/Development, Preliminary Diagnosis, Administrative Workflow
Assistance, Virtual Nursing Assistant, Fraud Detection, Dosage Error Reduction
and Others), by End User (Hospitals/Clinics/Healthcare Providers, Medical
Devices Companies, Pharmaceuticals & Biotechnology Companies and Others
Including Payers and Other Software Providers) and by Country (Japan, China,
Australia, India, Singapore and Rest of APAC) for the period 2013-2025. The
report also covers emerging growth drivers and trends; innovation, adoption and
application gap in comparison to US and Europe; case studies on various
healthcare application areas and competitive landscape of players in the market
with special focus on IBM, NVIDIA Corporation, Intel, Microsoft Corporation,
iCarbonX, Alphabet Inc., Next IT Verint Corporation, Welltok Incorporation,
Oncora Medical, Entilic Incorporation, Koninklijke Philips and General
Vision. The interpretation explores
investment trends in the market, major funding opportunities by stage,
potential markets of investment activity along with future outlook &
projections highlighting the major opportunities & cautions to the reader.
This report will particularly help the readers to identify the ongoing trends
in the industry and anticipated growth in the future depending upon changing
industry dynamics in upcoming years.
APAC AI in Healthcare Market Summary
Market
Overview: APAC AI in Healthcare Market has witnessed strong growth owing to
rising number of collaborations, investments and partnerships among hospitals,
healthcare providers, AI developers and medical device manufacturers; improved
accuracy and predictive capacity of AI powered devices, limited number of
skilled healthcare professionals in developing countries such as China and
India and over the years advancements in processor design and manufacturing
techniques across Asia Pacific region. The market size by revenue witnessed a
five year CAGR of close to 56% during the review period (2013-2018) due to the
combined effect of these factors. The market is currently placed in high growth
stage with strong possibility for further innovations and developments at a
faster pace with positive trends expected in the industry.
Market Segmentations
By Technology (Deep Learning, Querying
Method, Natural Language Processing and Context Aware Processing)
APAC
AI in Healthcare Market incorporates various technologies such as Deep Learning
Method, Natural Language Processing and Context Aware Processing. In 2018,
majority of the revenue was contributed by Natural Language Processing method
owing to its high application in health robots, hospital management systems and
decision making services. This was followed by Querying Method which
contributed second highest share to the total revenue in 2018. The remaining
share was contributed by Context Aware Processing and Deep Learning Method.
By Application (Machine/Robot Assisted
Medical Procedures, Clinical Trial & Drug Discovery/Development,
Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing
Assistant, Fraud Detection, Dosage Error Reduction and Others)
APAC
AI in Healthcare Market application areas include Machine/Robot Assisted
Medical Procedures, Clinical Trial & Drug Discovery/Development,
Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing
Assistant, Fraud Detection, Dosage Error Reduction and Others (including
Fitness & Wellness Tech Devices). In 2018, highest contribution to overall
revenue was made by machine/robot assisted medical procedures owing to high
robot costs and limited technical capabilities in Asia Pacific region. Second
highest contribution to revenue was made by clinical trial & drug
discovery/development and preliminary diagnosis owing to its application in
multiple fields. This was followed by administrative workflow assistance,
virtual nursing assistant, fraud detection, dosage error reduction and others
(including Fitness & Wellness Tech (Physical Fitness, Mind & Body
Wellness).
By End Users
(Hospitals/Clinics/Healthcare Providers, Medical Devices Companies,
Pharmaceuticals & Biotechnology Companies and Others Including Payers and
Other Software Providers)
APAC
AI in Healthcare majorly includes four categories of end users including
Hospitals/Clinics/Healthcare Providers, Medical Devices Manufacturers or
Companies, Pharmaceuticals & Biotechnology Companies and Others, including
Payers and Other Software Providers. In 2018, highest proportion of revenue was
contributed by Hospitals/Clinics/Healthcare Providers. Factors driving demand
in Hospitals and healthcare centers includes high application of AI in overall
management of hospitals through usage of several healthcare management
software, high adoption of AI in medical devices and machineries used in
hospitals, AI being used for mundane tasks in order to reduce workload of
doctors, nurses and others. Medical device manufacturers were seen to be the
second highest contributor to revenue in 2018. This was followed by
Pharmaceuticals & Biotechnology Companies and Others Including Payers and
Other Software Providers.
By Country (Japan, China, Australia,
India, Singapore and Rest of APAC)
In
global scenario, Asia Pacific region is one of the fastest growing regions with
presence of leading companies such as IBM, Microsoft, Google and others. In
terms of technological developments and innovations, Japan and China are seen
to be fastest growing nations in Asia Pacific region. In 2018, Japan
contributed highest revenue to the overall revenue generated in AI healthcare
market in Asia Pacific region followed by China with very low difference. Other
APAC countries such as Thailand and Malaysia were noted to be the third largest
revenue contributors in the region owing to factors such as high AI adoption
rate in these countries. This was followed by Australia, India and Singapore.
Competitive Landscape in APAC AI in
Healthcare Market: The nature of
APAC AI in Healthcare Market differs on the basis of the number of players and
share in overall revenue generation. When analyzing on the basis of number of
players, the market is considered to be fragmented with high number of small
and large players present in the market though only few big players occupy the
highest revenue share. These include companies such as IBM, Microsoft,
iCarbonX, Alphabet Inc. and others. The major competing parameters in the
market include ease of AI integration in current systems and devices,
customization services offered in AI application software, accessibility and
number of patents earned.
APAC AI in Healthcare Market Future
Outlook and Projections: Over the
forecast period 2019-2025, APAC AI Healthcare Market is predicted to grow at a
CAGR of close to 54% in terms of revenue. Major growth in coming years will be
supported by factors such as supportive legislative regulations, high
investments by new startups and already established companies looking for
expansion, innovations and developments for new products and others.
Key Segments Covered in APAC AI in
Healthcare Market
By Technology (On the basis of
Revenue)
Deep
Learning Method
Querying
Method
Natural
Language Processing
Context
Aware Processing
By Application (On the basis of
Revenue)
Machine/Robot
Assisted Medical Procedures
Clinical
Trial & Drug Discovery/Development
Preliminary
Diagnosis
Administrative
Workflow Assistance
Virtual
Nursing Assistant
Fraud
Detection
Dosage
Error Reduction
Others
(including Fitness & Wellness Tech (Physical Fitness, Mind & Body
Wellness)
By End Users (On the basis of Revenue)
Hospitals/Clinics/Healthcare
Providers
Medical
Devices Companies
Pharmaceuticals
& Biotechnology Companies
Others
Including Payers and Other Software Providers
By Country (On the basis of Revenue)
Japan
China
Australia
India
Singapore
Rest
of APAC
Key Target Audience
Hospitals,
Clinics and Healthcare Providers
Medical
Device Manufacturers
Insurance
Providers
AI
Developers
Healthcare
Software Providers
Pharmaceuticals
& Biotechnology Companies
Research
Institutes
Venture
Capital Firms
Time Period Captured in the Report:
Historical Period – 2013-2018
Forecast Period – 2019-2025
Companies Covered:
IBM
NVIDIA
Corporation
Intel
Microsoft
Corporation
iCarbonX
Alphabet
Inc.
Next
IT Verint Corporation
Welltok
Incorporation
Oncora
Medical
Entilic
Incorporation
Koninklijke
Philips
General
Vision
Key Topics Covered in the Report
APAC
AI in Healthcare Value Chain & Ecosystem
APAC
AI in Healthcare Market Size Analysis, 2013– 2018
APAC
Healthcare AI Market Segmentation, 2013-2025E
Innovation,
Adoption and Application Gap - Comparison of APAC with Europe & US
Regulatory
Framework in APAC AI in Healthcare Market
Case
Studies on Various Application Areas of AI in Healthcare, 2013-2018
Competitive
Landscape in APAC AI in Healthcare Market, 2018
Company
Profiling Of Major Players Operating in APAC Artificial Intelligence in
Healthcare Market
Investment
Scenario- Healthcare in AI, 2018
Taxonomy
Markets
of Investment Activity
Future
Market Sizing Analysis, 2019E-2025E
For more information, refer to below
link:
Related Reports
Contact Us:
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
